Abstract:Macrophages play critical roles in tumor progression. In the tumor microenvironment, macrophages display highly diverse phenotypes and may perform antitumorigenic or protumorigenic functions in a context-dependent manner. Recent studies have shown that macrophages can be engineered to transport drug nanoparticles (NPs) to tumor sites in a targeted manner, thereby exerting significant anticancer effects. In addition, macrophages engineered to express chimeric antigen receptors (CARs) were shown to actively migrate to tumor sites and eliminate tumor cells through phagocytosis. Importantly, after reaching tumor sites, these engineered macrophages can significantly change the otherwise immune-suppressive tumor microenvironment and thereby enhance T cell-mediated anticancer immune responses. In this review, we first introduce the multifaceted activities of macrophages and the principles of nanotechnology in cancer therapy and then elaborate on macrophage engineering via nanotechnology or genetic approaches and discuss the effects, mechanisms, and limitations of such engineered macrophages, with a focus on using live macrophages as carriers to actively deliver NP drugs to tumor sites. Several new directions in macrophage engineering are reviewed, such as transporting NP drugs through macrophage cell membranes or extracellular vesicles, reprogramming tumor-associated macrophages (TAMs) by nanotechnology, and engineering macrophages with CARs. Finally, we discuss the possibility of combining engineered macrophages and other treatments to improve outcomes in cancer therapy.

Engineering extracellular vesicles derived from macrophages for tumor therapy: a review

Tumor Cell-derived Extracellular Vesicles in Modulating Phenotypes and Immune Functions of Macrophages: Mechanisms and Therapeutic Applications.

Extracellular Vesicles Derived from Macrophages: Current Applications and Prospects in Tumors

Exosomes: A Potential Therapeutic Tool Targeting Communications Between Tumor Cells and Macrophages.

Engineering macrophages and their derivatives: A new hope for antitumor therapy

Roles of M1 Macrophages and Their Extracellular Vesicles in Cancer Therapy

Small Extracellular Vesicles-Mediated Cellular Interactions Between Tumor Cells and Tumor-Associated Macrophages: Implication for Immunotherapy.

Extracellular vesicles derived from immune cells: Role in tumor therapy

Emerging Applications of Extracellular Vesicles in Tumor Therapy

Extracellular Vesicles for Improved Tumor Accumulation and Penetration

Engineering Macrophages <i>via</i> Nanotechnology and Genetic Manipulation for Cancer Therapy

Application of engineered extracellular vesicles for targeted tumor therapy

Extracellular vesicles reshape the tumor microenvironment to improve cancer immunotherapy: Current knowledge and future prospects

Engineered extracellular vesicles: A new approach for targeted therapy of tumors and overcoming drug resistance

The Role of Extracellular Vesicles in Tumor Therapy and Imaging

Tumor-derived Extracellular Vesicles: Regulators of Tumor Microenvironment and the Enlightenment in Tumor Therapy

Immune Cell-Derived Extracellular Vesicles – New Strategies in Cancer Immunotherapy

Engineering Macrophages for Cancer Immunotherapy and Drug Delivery

Extracellular vesicles remodel tumor environment for cancer immunotherapy

Tumor-derived microvesicles for cancer therapy

Engineering extracellular vesicles for cancer therapy: recent advances and challenges in clinical translation